Clinical practice:: Monoclonal gammopathy of undetermined significance

被引：77

作者：

Blade, Joan ^{[1
]}

机构：

[1] Univ Barcelona Hosp Clin, Dept Hematol, ICMHO,IDIBAPS, Postgrad Sch Hematol Farreras Valenti, E-08036 Barcelona, Spain

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 26期

关键词：

D O I：

10.1056/NEJMcp052790

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2765 / 2770

页数：6

共 31 条

[1]

AXELSSON U, 1986, ACTA MED SCAND, V219, P519

[2] Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy [J].

Baldini, L ;

Guffanti, A ;

Cesana, BM ;

Colombi, M ;

Chiorboli, O ;

Damilano, I ;

Maiolo, AT .

BLOOD, 1996, 87 (03) :912-918

[3]

BERGSAGEL PL, 2004, MYELOMA BIOL MANAGEM, P35

[4] MALIGNANT TRANSFORMATION AND LIFE EXPECTANCY IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE [J].

BLADE, J ;

LOPEZGUILLERMO, A ;

ROZMAN, C ;

CERVANTES, F ;

SALGADO, C ;

AGUILAR, JL ;

VIVESCORRONS, JL ;

MONTSERRAT, E .

BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (03) :391-394

[5] On the "Significance" of monoclonal Gammopathy of undetermined significance [J].

Bladé, J .

MAYO CLINIC PROCEEDINGS, 2004, 79 (07) :855-856

[6] Renal failure in multiple myeloma -: Presenting features and predictors of outcome in 94 patients from a single institution [J].

Bladé, J ;

Fernández-Llama, P ;

Bosch, F ;

Montoliu, J ;

Lens, XM ;

Montoto, S ;

Cases, A ;

Darnell, A ;

Rozman, C ;

Montserrat, E .

ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (17) :1889-1893

[7] Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance [J].

Bladé J. ;

Rosiñol L. .

Current Treatment Options in Oncology, 2006, 7 (3) :237-245

[8] Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma [J].

Cesana, C ;

Klersy, C ;

Barbarano, L ;

Nosari, AM ;

Crugnola, M ;

Pungolino, E ;

Gargantini, L ;

Granata, S ;

Valentini, M ;

Morra, E .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1625-1634

[9]

FONSECA R, 2004, MYELOMA BIOL MANAGEM, P67

[10]

Gregersen H, 2001, HAEMATOLOGICA, V86, P1172

← 1 2 3 4 →